Pitt/UPMC to Lead $19.2 Million Trial to Test Red Cell Exchange in Sickle Cell Disease
Health Sciences at the University of PittsburghPatients with sickle cell disease experience severe organ damage leading to early death. An international clinical trial funded by the NIH will test whether red cell exchange, which replaces sicked red blood cells with normal ones could prevent or reverse organ damage and prolong life.